Linzolid 2 mg/ml (IV Infusion)
300 ml solution: ৳ 450.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linezolid |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Title
- Linzolid Tablets
- Linzolid IV Infusion
Categories
- Medication
- Antibacterial Agent
- Pharmaceutical
Description
- Synthetic Antibacterial Agent
- Treatment for Nosocomial Pneumonia
- Treatment for Community-Acquired Pneumonia
- Treatment for Skin and Skin Structure Infections
- Oxazolidinones Class of Antibiotics
- Selective Bacterial Protein Synthesis Inhibitor
- Bacteriostatic and Bactericidal Effects
Color Options
- White Tablets
- Clear IV Infusion Solution
Dosage Form
- Tablets
- IV Infusion
Dosage Administration
- Oral Route
- Intravenous Infusion
- Daily Dosage Table
- No Dose Adjustment Required for Switching from IV to Oral Administration
Pharmacological Action
- Inhibits Bacterial Protein Synthesis
- Binds to 23S Ribosomal RNA
- Prevents Formation of 70S Initiation Complex
- Bacteriostatic Against Enterococci and Staphylococci
- Bactericidal for Most Strains of Streptococci
Interaction with Medication
- Reversible Inhibitor of Monoamine Oxidase
- Potential Interaction with Adrenergic and Serotonergic Agents
Interaction with Food
- Avoid Large Quantities of Foods or Beverages with High Tyramine Content
Contraindications
- Hypersensitivity to Linezolid or Components
- Concurrent Use with Monoamine Oxidase Inhibitors
- Uncontrolled Hypertension
- Pheochromocytoma
- Thyrotoxicosis
- Serotonergic and sympathomimetic agents
Side Effects
- Mild to Moderate Adverse Events
- Commonly Diarrhea, Headache, Nausea
- Includes Hypertension, Dyspepsia, Pruritus
Pregnancy & Lactation
- Limited Data on Use in Pregnancy
- Presence in Breast Milk
- Consideration of Benefits vs. Risks for Breastfeeding Women
Precautions & Warnings
- Monitoring of Complete Blood Counts
- Ophthalmic Evaluation for Visual Impairment Symptoms
- Not Approved for Catheter-related Infections
- Clostridium difficile-associated Diarrhea Risk
- Monitoring for Potential Increases in Blood Pressure
- Potential for Recurrent Nausea or Vomiting
- Hypoglycemia Caution
Overdose Effects
- No Reported Cases of Overdose
- Symptomatic and Supportive Care Recommended
- Partial Removal during Hemodialysis
Therapeutic Class
- Macrolides
Reconstitution
- Shake Oral Suspension Well
- Reconstituted Suspension Storage Guidelines
- Intravenous Administration Instructions
Storage Conditions
- Room Temperature Storage
- Protection from Light and Moisture